CF PharmTech Overview
- Year Founded
-
2007
- Status
-
Public
- Employees
-
625
- Stock Symbol
-
02652
- Share Price
-
$0.62
- (As of Friday Closing)
CF PharmTech General Information
Description
CF PharmTech Inc is engaged in inhalation drug delivery technology. It is dedicated to building multidisciplinary bridges between complex formulations and unmet clinical needs. The Company is a specialist in the development of complex inhalation formulations with high barriers to entry, and a platform-based pharmaceutical company with integrated capabilities spanning device engineering, precision drug delivery, international regulatory filing, and commercialization. Leveraging its self-developed, globally integrated end-to-end capabilities, from exhalation-powered nasal spray delivery systems and liposomal inhalation technology to small interfering RNA (siRNA) nucleic acid delivery platforms. Its therapeutic areas encompass respiratory diseases and nasal diseases.
Contact Information
Website
www.cfpharmtech.comCorporate Office
- Number16, Hucundang Road
- Xiangcheng Economic Development Zone
- Suzhou, Jiangsu 215000
- China
Corporate Office
- Number16, Hucundang Road
- Xiangcheng Economic Development Zone
- Suzhou, Jiangsu 215000
- China
CF PharmTech Stock Performance
As of 13-Nov-2026, CF PharmTech’s stock price is $0.62. Its current market cap is $267M with 432M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.62 | $0.65 | $0.62 - $5.05 | $267M | 432M | 2.97M |
CF PharmTech Financials Summary
As of 30-Jun-2026, CF PharmTech has a trailing 12-month revenue of $62.4M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 911,433 | 1,874,614 | ||
| Revenue | 62,423 | 60,145 | 84,699 | 78,647 |
| EBITDA | 6,970 | 7,717 | 11,226 | 10,296 |
| Net Income | (971) | 346 | 2,939 | 4,484 |
| Total Assets | 255,731 | 253,872 | 172,467 | 160,137 |
| Total Debt | 31,251 | 20,804 | 10,835 | 3,091 |
CF PharmTech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CF PharmTech Comparisons
Industry
Financing
Details
CF PharmTech Competitors (1)
One of CF PharmTech’s competitors is Pulmatrix, a Formerly VC-backed company based in Framingham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pulmatrix | Formerly VC-backed | Framingham, MA |
CF PharmTech Patents
CF PharmTech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026214612-A1 | Sirna for inhibiting mmp7, modified form thereof, and use thereof | Pending | 10-Apr-2025 | ||
| WO-2026179900-A1 | Sirna for inhibiting tslp, and modified form and use thereof | Pending | 28-Feb-2025 | ||
| WO-2026144627-A1 | Dry powder composition of treprostinil derivative, and use thereof | Pending | 31-Dec-2024 | ||
| WO-2026050883-A1 | Atomization drug delivery device | Pending | 03-Sep-2024 | ||
| FR-3165784-A3 | Atomizing drug delivery device | Pending | 03-Sep-2024 | A61M15/0021 |
CF PharmTech Signals
CF PharmTech ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
CF PharmTech FAQs
-
When was CF PharmTech founded?
CF PharmTech was founded in 2007.
-
Where is CF PharmTech headquartered?
CF PharmTech is headquartered in Suzhou, China.
-
What is the size of CF PharmTech?
CF PharmTech has 625 total employees.
-
What industry is CF PharmTech in?
CF PharmTech’s primary industry is Drug Delivery.
-
Is CF PharmTech a private or public company?
CF PharmTech is a Public company.
-
What is CF PharmTech’s stock symbol?
The ticker symbol for CF PharmTech is 02652.
-
What is the current stock price of CF PharmTech?
As of 13-Nov-2026 the stock price of CF PharmTech is $0.62.
-
What is the current market cap of CF PharmTech?
The current market capitalization of CF PharmTech is $267M.
-
What is CF PharmTech’s current revenue?
The trailing twelve month revenue for CF PharmTech is $62.4M.
-
Who are CF PharmTech’s competitors?
Pulmatrix is a competitor of CF PharmTech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process